Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Zahnreich, S.; Gebrekidan, S.; Brieger, J. et al.
Oxygen deprivation modulates EGFR expression and activity in squamous cell carcinomas of the head and neckSTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 196. H. SUPPL 1. 2020 S. S14-S14
Levy, Antonin; Wagner, Anna D.; Chargari, Cyrus et al.
Palliation of dysphagia in metastatic oesogastric cancers: An international multidisciplinary positionEUROPEAN JOURNAL OF CANCER. Bd. 135. 2020 S. 103-112
Frappart, Pierre-Olivier; Hofmann, Thomas G.
Pancreatic Ductal Adenocarcinoma (PDAC) Organoids: The Shining Light at the End of the Tunnel for Drug Response Prediction and Personalized MedicineCANCERS. Bd. 12. H. 10. 2020
Galle, Peter R.; Finn, Richard S.; Qin, Shukui et al.
Patient-reported outcomes (PROs) from the Phase III IMbrave150 trial of atezolizumab (atezo) plus bevacizumab (bev) vs sorafenib (sor) as first-line treatment (tx) for patients (pts) with unresectable hepatocellular carcinoma (HCC)JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 4. 2020
Locati, Laura D.; Galbiati, Donata; Calareso, Giuseppina et al.
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of lifeCANCER. 2020
Reig, Maria; Galle, Peter R.; Kudo, Masatoshi et al.
Pattern of progression in advanced HCC treated with ramucirumab/placebo: Results from two randomized phase III trials (REACH/REACH-2)JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 4. 2020
Reig, Maria; Galle, Peter R.; Kudo, Masatoshi et al.
Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumabLIVER INTERNATIONAL. 2020
Schattenberg, Joern M.; Labenz, Christian; Woerns, Marcus-Alexander et al.
Patterns of liver injury in COVID-19-a German case seriesUNITED EUROPEAN GASTROENTEROLOGY JOURNAL. Bd. 8. H. 7. 2020 S. 814-819
Smyth, Elizabeth C.; Moehler, Markus
Pembrolizumab in First-line Gastric Cancer: Win, Lose, or Draw?JAMA ONCOLOGY. Bd. 6. H. 10. 2020 S. 1539-1541
Waldschmidt, D.; El-Khoueir, A. B.; Kim, R. D. et al.
Phase 1b study of regorafenib (REG) plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC)ONCOLOGY RESEARCH AND TREATMENT. Bd. 43. H. SUPPL 4. 2020 S. 123-123